Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR25F8QLQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,867
Award facts
- Contract value 100% obligated
- $10,866.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,866.93 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injections on August 21, 2025, with completion targeted for August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables global pharmaceutical support across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. As the prime contractor under the DLA Troop Support Medical IDC, the company demonstrates capability to meet federal procurement requirements across multiple therapeutic domains. The delivery of Zepbound, a diabetes management medication, aligns with the company's track record of supplying specialized pharmaceutical products to support military healthcare programs worldwide under firm fixed-price delivery orders.
Quick answers
Who was awarded contract SPE2DR25F8QLQ?
SPE2DR25F8QLQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DR25F8QLQ worth?
The government has obligated $10,867 on SPE2DR25F8QLQ.
Is contract SPE2DR25F8QLQ an order under another contract?
Yes. SPE2DR25F8QLQ is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DR25F8QLQ competed?
The extent of competition for SPE2DR25F8QLQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award